News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
FDA Oncology – Overall Survival and PARP Inhibitors in Advanced Ovarian Cancer
Source: Depositphotos
May 28, 2025, 07:50

FDA Oncology – Overall Survival and PARP Inhibitors in Advanced Ovarian Cancer

FDA Oncology posted on X:

“FDA article outlines the decision-making process and rationale behind removal or narrowing of certain indications for PARP inhibitors in treatment of advanced ovarian cancer – via Journal of Clinical Oncology.”

Title: Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer

Authors: Mirat Shah, Ting-Yu Chen, Gwynn Ison, Mallorie H. Fiero, Hui Zhang, Xin Gao, Marc Neilson, Kirsten B. Goldberg, Abhilasha Nair, Tiffany K. Ricks, William F. Pierce, Nicole Gormley, Marc R. Theoret, Shenghui Tang, Richard Pazdur, Paul G. Kluetz, Laleh Amiri-Kordestani

Read The Full Article at ASCO Publications.

FDA Oncology - Overall Survival and PARP Inhibitors in Advanced Ovarian Cancer

More posts featuring Ovarian Cancer.

Abhilasha Nair cancer FDA Oncology Gwynn Ison Hui Zhang Journal of Clinical Oncology Kirsten B. Goldberg Laleh Amiri-Kordestani Mallorie H. Fiero Marc Neilson Marc R. Theoret Mirat Shah Nicole Gormley OncoDaily Oncology Ovarian Cancer Paul G Kluetz Richard Pazdur Shenghui Tang Tiffany K. Ricks Ting-Yu Chen William F. Pierce Xin Gao
Special Coverage
Blog
May 29, 2025, 14:19
Anna Cabanes on ATOM Coalition's Milestone in Global Cancer Access Program at the Recent Workshop in Zambia
Insight
May 29, 2025, 14:15
New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer
Opinion
May 29, 2025, 13:47
Robin Zon and Andy Guinigundo Highlighted the Importance of Team Attendance at ASCO 2025
Blog
May 29, 2025, 13:35
Habib Nehmé Highlights Elekta’s Record Fourth Quarter and Global Teamwork
Opinion
May 29, 2025, 13:32
List of 10 ADC Presentations Not to Miss at the ASCO 2025 Curated by Paolo Tarantino and Raffaele Colombo
Blog
May 29, 2025, 13:16
Dana Bryson Highlights ACT for Children's Progress in Expanding Pediatric Cancer Access
Insight
May 29, 2025, 13:11
START and OneOncology Partner to Expand Access to Early-Phase Oncology Trials
Blog
May 29, 2025, 13:01
Ruben Mesa: Wonderful panel at CancerX by members of our Advocate Health Cancer National Service Line
Blog
May 29, 2025, 12:53
Aleix Prat: Representing Both the Clínic Barcelona Comprehensive Cancer Center and Reveal Genomics at ASCO25
Blog
May 29, 2025, 12:46
Honoring World Blood Cancer Day 2025: A Global Call to Action and Hope
Blog
May 29, 2025, 12:43
UICC Highlights AI and Biomarker Advances in Lung Cancer Detection and Treatment
Opinion
May 29, 2025, 12:40
Esophageal Cancer and Proton Radiation Therapy: Aren Karapetyan Highlights Promising Results from New Study